Cammarata, E. (2025) “Impact of Disease Activity-Guided Dose Reduction on IL-17 and IL-23 Inhibitors in Psoriasis: A Real-World Assessment of Efficacy, Safety, and Economic Benefits”, Dermatology Practical & Conceptual, 15(3), p. 5845. doi:10.5826/dpc.1503a5845.